Stock Track | ANI Pharmaceuticals Plummets 5.17% Intraday Despite Strong Earnings as Health Care Sector Weakens

Stock Track

02/28

ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.

The pharmaceutical firm posted fourth-quarter adjusted earnings of $2.33 per share, surpassing the analyst consensus estimate of $2.00. Revenue for the quarter reached $247.1 million, a 29.6% year-over-year increase that also exceeded expectations, driven by a 50.8% surge in Rare Disease segment sales.

The sharp decline occurred amid broader weakness in the health care sector, with the State Street Health Care Select Sector SPDR ETF (XLV) falling 0.3% in pre-market trading. Market participants appeared to engage in profit-taking following the earnings beat, a common "sell the news" reaction, particularly as technical indicators had previously signaled bearish pressure with the MACD below its signal line.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1111911116"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1111911116\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1111911116?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-28 00:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111911116","market":"nz","top_or_hot":-1,"title":"Stock Track | ANI Pharmaceuticals Plummets 5.17% Intraday Despite Strong Earnings as Health Care Sector Weakens","media":"Stock Track","content":"<p>ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.</p><p>The pharmaceutical firm posted fourth-quarter adjusted earnings of $2.33 per share, surpassing the analyst consensus estimate of $2.00. Revenue for the quarter reached $247.1 million, a 29.6% year-over-year increase that also exceeded expectations, driven by a 50.8% surge in Rare Disease segment sales.</p><p>The sharp decline occurred amid broader weakness in the health care sector, with the State Street Health Care Select Sector SPDR ETF (XLV) falling 0.3% in pre-market trading. Market participants appeared to engage in profit-taking following the earnings beat, a common \"sell the news\" reaction, particularly as technical indicators had previously signaled bearish pressure with the MACD below its signal line.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ANI Pharmaceuticals Plummets 5.17% Intraday Despite Strong Earnings as Health Care Sector Weakens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ANI Pharmaceuticals Plummets 5.17% Intraday Despite Strong Earnings as Health Care Sector Weakens\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-28 00:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.</p><p>The pharmaceutical firm posted fourth-quarter adjusted earnings of $2.33 per share, surpassing the analyst consensus estimate of $2.00. Revenue for the quarter reached $247.1 million, a 29.6% year-over-year increase that also exceeded expectations, driven by a 50.8% surge in Rare Disease segment sales.</p><p>The sharp decline occurred amid broader weakness in the health care sector, with the State Street Health Care Select Sector SPDR ETF (XLV) falling 0.3% in pre-market trading. Market participants appeared to engage in profit-taking following the earnings beat, a common \"sell the news\" reaction, particularly as technical indicators had previously signaled bearish pressure with the MACD below its signal line.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ANIP","symbol_name":"ANI Pharmaceuticals, Inc.","start_time":0,"source_url":"","article_id":"1111911116","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111911116","pubTimestamp":1772209464,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ANIP":"ANI Pharmaceuticals, Inc."},"translate_title":"个股追踪|ANI制药盘中暴跌5.17%尽管医疗保健板块走弱盈利强劲","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANIP":1},"content_text":"ANI Pharmaceuticals Inc. (ANIP) shares plummeted 5.17% during intraday trading on Friday, marking a significant downturn despite the company reporting record quarterly financial results.The pharmaceutical firm posted fourth-quarter adjusted earnings of $2.33 per share, surpassing the analyst consensus estimate of $2.00. Revenue for the quarter reached $247.1 million, a 29.6% year-over-year increase that also exceeded expectations, driven by a 50.8% surge in Rare Disease segment sales.The sharp decline occurred amid broader weakness in the health care sector, with the State Street Health Care Select Sector SPDR ETF (XLV) falling 0.3% in pre-market trading. Market participants appeared to engage in profit-taking following the earnings beat, a common \"sell the news\" reaction, particularly as technical indicators had previously signaled bearish pressure with the MACD below its signal line.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}